Loading clinical trials...
Loading clinical trials...
This is a single-arm, multicenter, exploratory study to evaluate the efficacy and safety of AK104 in combination with cisplatin and paclitaxel in the treatment of resectable locally advanced esophagea...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Guangzhou Institute of Respiratory Disease
NCT04771520 · Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, and more
NCT07530094 · Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
NCT07388771 · NSCLC, Neoadjuvant Therapy
NCT04511039 · Advanced Malignant Solid Neoplasm, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, and more
NCT07389629 · Iparomlimab and Tuvonralimab, Clear Cell Renal Cell Carcinoma, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions